Brit-PACT Committee Elections 2025
Following a tie at this year’s AGM, please could we ask for your vote for the steering committee vacancy for Brit-PACT.
The two new nominees are listed below. If you need any other additional information, please contact info@britpact.org.
Thank you for your vote!
The Brit-PACT Steering Committee
Full details on each of the candidates can be found here:
Dr Richard Smith - Clinical Lead for Rheumatology, Salisbury Foundation Trust
I am clinical lead for Rheumatology at Salisbury Foundation Trust and visiting consultant to King Edward memorial hospital in the Falkland Islands. I sit on the British society Rheumatology Heberden’s committee, having previously sat on both the clinical affairs committee and education committee.
I run a weekly dedicated psoriatic arthritis biologics clinic and monthly joint dermatology/ rheumatology psoriatic disease clinic in Salisbury. I am PI for several clinical trials including several in the field of Psoriatic arthritis. I am an active member of GRAPPA and sit on the working group updating guidelines for comorbidities in Psoriatic disease. I sit on the executive committee for the Wessex Psoriatic Disease Network having been a founder member. I am a member of Brit-PACT and have attended virtually the last 3 annual meetings.
I am keen to become a member of the Steering committee of Brit-PACT. I believe I have shown my commitment in current and previous committee roles and would describe myself as a reliable and enthusiastic committee member with a reputation for achievement.
Dr Carmel Stober - Consultant Rheumatologist, Cambridge University Hospitals NHS Foundation Trust
I am a Consultant Rheumatologist based at Cambridge University Hospital. I have a sub-specialist interest in Psoriatic Arthritis, where I co-established (with Dr Deepak Jadon) and now lead the Psoriatic arthritis service. We work collaboratively with Dermatology (monthly MDT) and Gastroenterology (bi-monthly MDT), to optimise patient outcomes and therapeutic choices according to disease domains and patient preferences.
During my National Institute for Health Research Clinical Lectureship (University of Cambridge), I undertook basic research evaluating Th17 cells, and factors that expand pathogenic subsets in Psoriatic disease. In particular, the association of ‘metabolic stress’ and pathogenic Th17 expansion in Psoriatic arthritis (published July 2025). I have published on precision medicine in, and the aetiopathogenesis of, Psoriatic disease; as well as evaluating factors influencing biologic persistence in Psoriatic arthritis. As a member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), and trainee representative on the GRAPPA Research Collaboration Network, I co-organised, presented and co-authored meeting proceedings, and contributed to international research initiatives. I have been principal investigator/ co-investigator in several clinical studies. My philosophy is that collaborative working facilitates precision medicine and thus optimises patient outcomes in heterogenous conditions such as Psoriatic Arthritis.
if you need any other additional information, please contact info@britpact.org.
Thank you for your vote!
The Brit-PACT Steering Committee